EFSA Journal

Statement on in vitro protein digestibility tests in allergenicity and protein safety assessment of genetically modified plants

This statement supplements and updates the GMO Panel guidance document on allergenicity of genetically modified (GM) plants published in 2017. In that guidance document, the GMO Panel considered that additional investigations on in vitro protein digestibi ...

Outcome of the public consultation on the draft Scientific Opinion on the applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide...

The European Food Safety Authority (EFSA) carried out a public consultation to receive input from interested parties on the applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐direct ...

Outcome of a public consultation on the draft adequacy and sufficiency evaluation of existing EFSA guidelines for the molecular characterisation, environmental risk assessment and post‐market environmental monitoring of genetically modified insects...

The European Food Safety Authority (EFSA) carried out an online public consultation to receive input from interested parties/persons on the draftscientific opinion on the adequacy and sufficiencyevaluation of existing guidelines for the molecular characte ...

Outcome of the public consultation on the draft Scientific Opinion on the evaluation of existing guidelines for their adequacy for the microbial characterisation and environmental risk assessment of micro‐organisms obtained through synthetic biology

The European Food Safety Authority (EFSA) carried out a public consultation to receive input from interested parties on the draft scientific opinion on the evaluation of existing guidelines for their adequacy for the microbial characterisation and environ ...

Assessment of the 2018 post‐market environmental monitoring report on the cultivation of genetically modified maize MON 810 in the EU

Following a request from the European Commission, the EFSA assessed the 2018 post‐market environmental monitoring (PMEM) report on the cultivation of Cry1Ab‐expressing maize event MON 810. Like previous years, there was partial compliance with refuge requ ...

EFSA's activities on emerging risks in 2019

The main objectives of EFSA's activities on emerging risks are: (i) to carry out activities to identify emerging risks; and (ii) to develop and improve emerging risk identification (ERI) methodologies and approaches and iii) communicate on identified ...

Assessment of the outcomes of the project “Risk Assessment of Genetically Engineered Organisms in the EU and Switzerland” (RAGES)

The R isk “Assessment of genetically engineered organisms in the EU and Switzerland” (RAGES) project (2016‐2019) evaluated the risk assessment of genetically modified plants (GMPs) as performed by the European Food Safety Authority (EFSA) and its Swiss co ...

Implemented activities under the EFSA Pre‐Accession programme 2017‐2019

European Union (EU) agencies (at the moment 12), including the European Food Safety Authority (EFSA) are active contributors to the EU Instrument for the Pre‐accession Assistance (IPA) programmes through the European Commission (EC) Multi‐country programm ...

Implemented activities under the EFSA Pre‐Accession programme 2015‐2017

European Union (EU) agencies (at the moment 12), including the European Food Safety Authority (EFSA) are active contributors to the EU Instrument for the Pre‐accession Assistance (IPA) programmes through the European Commission (EC) Multi‐country programm ...

Scientific advice on the Testbiotech's requests for internal review of Commission Implementing Decisions (EU) No 2019/2083 and 2019/2084 on soybean MON 89788 and soybean A2704‐12 (applications EFSA‐GMO‐RX‐011 and EFSA‐GMO‐RX‐009)

Following a request of the European Commission, the European Food Safety Authority (EFSA) reviewed the scientific arguments raised by the non‐governmental organisation Testbiotech against the Commission Implementing Decisions (EU) 2019/2083 and 2019/2084 ...

Seiten